Longevity Supplements:
Why Most Don't Work, the Few That Do, and What Actually Moves the Number

The category called longevity supplements is, by some estimates, a fifty-billion-dollar global market on its way to a hundred. The volume of bottles sold suggests an industry in robust health. The volume of high-quality clinical evidence behind those bottles tells a very different story. So a working article on the question, written from the same evidence-first frame as The Health Protocol, has to begin somewhere uncomfortable for the supplement aisle.

The Honest Starting Point

Most longevity supplements on the market today have not been shown to extend human lifespan, or even to lower biological age, in well-designed long-term trials. That is not a polemic; it is the current state of the evidence. The cell-culture data is often promising. The mouse data is often interesting. The translation to human outcomes is, with a small number of exceptions covered below, thin to absent.

This is not the fault of any particular brand. It is a structural problem with how supplement claims are regulated, how trials are funded, and how compounds get from a hopeful in-vitro result to a marketed product. The honest summary, as Santiago Vitagliano puts it in the seminar's article on magnesium and the food-first principle, is that the supplement industry has moved much faster than the evidence base, and consumers are often paying for compounds whose names sound rigorous but whose case in human longevity is at the level of educated speculation.

That said, the category is not uniformly empty. A small number of compounds have reasonable evidence in specific contexts. The rest of this article tries to be precise about which is which.

The Compounds With Evidence Worth Reading

Magnesium (especially glycinate)

Magnesium is involved in more than three hundred enzymatic reactions, and clinical deficiency is widespread in industrialized populations. Supplementation in deficient individuals improves sleep quality, glucose handling, blood pressure, and a number of downstream markers that are themselves correlated with biological age. The seminar's article on this is unusually direct: magnesium glycinate is well-tolerated, well-absorbed, and inexpensive, but food-first should be the working principle, and most people can hit their magnesium needs through pumpkin seeds, almonds, dark leafy greens, and legumes before reaching for a capsule.

Omega-3 fatty acids (EPA and DHA)

The cardiovascular evidence for omega-3 supplementation, particularly EPA, is mixed but on balance positive in individuals with elevated triglycerides or established cardiovascular risk. The seminar's explainer on triglycerides is one entry point. The cleanest food source is fatty fish; supplementation is reasonable when intake is low.

Vitamin D, in deficient populations

The vitamin-D-supplementation literature is messier than headlines suggest. The clearest signal: in individuals with serum 25(OH)D below 20 ng/mL, supplementation to bring the level into the 30–50 range improves multiple downstream markers, including ones tied to inflammation and bone density. In sufficient individuals, marginal supplementation does not seem to help. Test first.

Creatine monohydrate

Creatine is the rare supplement with both the safety profile and the evidence base most others lack. The longevity-relevant effects, lean-mass preservation, cognitive support, modest improvements in resistance-training capacity, show up reliably in older adults. Five grams a day, monohydrate, the cheapest brand. The literature has not yet definitively linked it to lower biological age, but the pathway is plausible and the cost-risk profile is favorable.

Fiber

Not a supplement in the marketing sense, but worth mentioning because it sits in the supplement aisle and does more for longevity than most of the compounds with bigger marketing budgets. Dietary fiber correlates strongly with all-cause mortality reduction in cohort data. Psyllium husk is the simplest, cheapest way to add to a deficient diet.

The Compounds Where the Marketing Has Run Ahead of the Evidence

NAD+ precursors (NR, NMN)

The most-marketed longevity compound of the last five years. The biology is genuinely interesting: cellular NAD+ declines with age, and restoring it produces real effects in mouse models. The translation to human longevity in well-designed long-term trials is, as of this writing, not yet there. Some markers move; some don't. The hundred-dollar bottles are paying for hope, not for established outcome. If you want to try it, do so understanding that you are early in the evidence cycle.

Resveratrol

Famous for the early sirtuin work that turned out to be more complicated than the headlines. The human evidence for resveratrol as a longevity supplement is thin. The compound itself has poor oral bioavailability, which complicates any read on the published trials.

Most adaptogen blends

Ashwagandha, rhodiola, holy basil, and similar herbs have some clinical evidence in narrow stress and fatigue contexts. The longevity claims layered on top of that evidence are mostly marketing. If you find an adaptogen helpful for stress regulation, that is a legitimate use; the longevity framing is a stretch.

Most "telomere" products

Telomere biology is fascinating. Consumer telomere-lengthening supplements have essentially no human longevity evidence. The marketing trades on a real piece of biology without delivering a real outcome.

The Category That Should Not Exist Yet

A growing share of longevity supplements market themselves as biological-age reversers, products promising to lower epigenetic age, restore mitochondrial function, or "reset" cellular aging. The serious research on biological age reversal, including the much-discussed work from Altos Labs and similar groups, is happening at the level of well-funded research labs with billion-dollar budgets and decades of expected timeline. The consumer products downstream of that research are nearly all premature.

This does not mean the underlying science is wrong. It is genuinely promising. It means that buying a forty-dollar bottle today and expecting your biological age to move because of it is, in 2026, mostly faith in marketing copy. Save the money for a real lab panel.

What Actually Moves Biological Age (Without a Bottle)

The frustrating answer, frustrating because it is unglamorous and frustrating because it is mostly free, is that the inputs that move biological age in the cohort literature are not supplements. They are the four or five things every honest longevity book ends up listing.

• Sleep regularity. Regularity outperforms duration as a predictor of all-cause mortality in recent UK Biobank work.
• A plant-predominant nutrition pattern, with adequate protein and limited ultra-processed food.
• Cardiovascular fitness, measurable through VO2max. Zone-2 cardio plus periodic higher-intensity work.
• Resistance training. Lean mass is one of the strongest single predictors of healthspan past age fifty.
• Stress regulation. Chronic allostatic load ages the body. Daily contemplative practice, time outdoors, simplification.
• Time-restricted eating, aligned with circadian biology. The seminar's article on intermittent fasting is the cleaner version of this; the popular framing is muddier than the underlying biology.

None of those costs more than a gym membership. All of them are better-supported than any supplement on the market.

Where Supplements Actually Fit

For most readers, the supplement stack that earns its place looks something like this, modest, evidence-tested, and assumed to be a complement to the inputs above, not a substitute for them.

• Magnesium glycinate if dietary intake is low, particularly for sleep support.
• Omega-3 (EPA/DHA) if fatty-fish intake is low.
• Vitamin D if blood levels are low.
• Creatine monohydrate, especially past age fifty.
• Fiber, in the form of food first and psyllium if needed.
• A standard multivitamin, only as cheap insurance against random gaps.

That list is not glamorous. It is, however, the list that an honest reading of the evidence supports. Everything beyond it is somewhere on a spectrum from reasonable speculation to active marketing fantasy.

If your goal is to improve quality of life, this is the book for you. Nicci Attfield, Reedsy Discovery

Books and Resources Worth Reading on This

Searches for longevity book and best longevity supplements return a wide range. A short, useful shelf:

• The Health Protocol by SAVI (Santiago Vitagliano). The food-first, evidence-grounded position the article above mostly summarizes. Chapter 1 is free.
• Peter Attia, Outlive: The Science and Art of Longevity. The longer, more clinical version of the same general project. Useful and rigorous.
• Valter Longo, The Longevity Diet. The fasting-mimicking diet research presented by the lead researcher.

For working content on the specific mechanisms, cellular energy, mitochondria, glucose regulation, the metabolic reset, the longevity framework, the seminar's open library is freely readable, alongside the glossary, the extended FAQ, and the full citations list (210 peer-reviewed sources).

The Single Most Useful Move

If you read no further, do this. Get a complete metabolic panel, fasting glucose, HbA1c, lipid panel including triglycerides, hsCRP, vitamin D, ferritin. Read the values honestly. Identify your two worst markers. Spend the next ninety days on the inputs that move those two markers. Recheck. Adjust. Repeat.

The biological-age dividend from doing that, consistently, for one year is larger than the dividend from any supplement stack currently on the market. The food-first principle is not an aesthetic preference; it is what the evidence keeps returning to.

The shorter version: longevity supplements are mostly a category waiting for its evidence to catch up with its marketing. A small number of compounds earn their place; the rest are paying-for-hope. The inputs that genuinely move biological age, sleep, food, movement, stress, glucose, inflammation, are the inputs that have always moved it. The seminar exists because most readers benefit from a structured walk through that work, with the citations attached.